Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative

Arveen Kalapara(Monash University), Artitaya Lophatananon, Mieke Van Hemelrijck(Ghent University Hospital), Prokar Dasgupta(Guy's Hospital), Caroline M. Moore(Royal Free London NHS Foundation Trust), Christopher J. Logothetis(The University of Texas MD Anderson Cancer Center), Bruce J. Trock(Johns Hopkins University), Behfar Ehdaie(NewYork–Presbyterian Hospital), Anders Bjartell(Malmö University), J. Rubio‐Briones, Byung Ha Chung, Jonas Hugosson, Daan Nieboer(Erasmus MC), Vincent J. Gnanapragasam(University of Cambridge), Todd M. Morgan(Michigan Cancer Research Consortium), Jozien Helleman(Erasmus MC), Jeri Kim(The University of Texas MD Anderson Cancer Center), Lee Lui Shiong(Singapore General Hospital), Kenneth Muir(University of Warwick), Antti Rannikko(Royal Free London NHS Foundation Trust), Monique J. Roobol(Erasmus MC), Jan Verbeek(Erasmus MC), Michael Fahey, Tim Hulsen(Philips (Spain)), Arnauld Villers(Royal Free London NHS Foundation Trust), Peter R. Carroll(University of California, San Francisco), Theodorus van der Kwast(Erasmus MC), Mark Frydenberg(Monash University), Lukas Hefermehl, Tom Pickles, Henk Obbink, Cees de Jonge, Tim Harkin(Monash University), Laurence Klotz, Antoinette S. Perry, Yoshiyuki Kakehi(Kagawa University), Lui Shiong Lee(Singapore General Hospital), Ewout W. Steyerberg(Erasmus MC), Christopher P. Filson(Emory University), Wim van der Linden(Philips (Netherlands)), Eric Hyndman, Chris H. Bangma(Erasmus MC), Xinge Ji(Cleveland Clinic), R. Valdagni
European Urology Oncology
September 26, 2019
Cited by 37


Related Papers